Antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products
The objective of the draft reflection paper is to review available information on the emissions and the environmental fate of veterinary medicinal products as sources of antimicrobial resistance (AMR) and antimicrobial resistant genes to and within the environment, and their risk to human and animal health. The document considers the suitability of the current risk assessment process for AMR and risk mitigation recommendations, and notes knowledge gaps and research needs.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.